Concepedia
Statistics
Publications
6
Citations
270
H-Index
Active since
2018
Affiliations
University of California, San Francisco(Current)
UCSF Helen Diller Family Comprehensive Cancer Center
University of California San Diego
University of California, Davis
Instituto de Salud Carlos III
David V. Allegakoen is an author at University of California, San Francisco specializing in oncology, molecular oncology, and medicine.
Publications per year
2018–2024
Differential Subcellular Localization Regulates Oncogenic Signaling by ROS1 Kinase Fusion Proteins
Dana S. Neel, David V. Allegakoen, Victor Olivas et al. · Cancer Research · 2018 · 96 citations · Full text
Life Sciences, Molecular Biology, Oncology +17
Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer
Franziska Haderk, Yu‐Ting Chou, Lauren Čech et al. · Nature Communications · 2024 · 87 citations · Full text
Medicine, Cancer Biology, Oncology +17
Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99
Haydar Çelik, Marika Sciandra, B. Flashner et al. · Oncogene · 2018 · 36 citations · Full text
Medicine, Oncology, Pharmacology +12
Synthetic Essentiality of Metabolic Regulator PDHK1 in PTEN-Deficient Cells and Cancers
Nilanjana Chatterjee, Evangelos Pazarentzos, Manasi K. Mayekar et al. · Cell Reports · 2019 · 22 citations · Full text
Medicine, Molecular Biology, Oncology +17
A focal adhesion kinase-YAP signaling axis drives drug tolerant persister cells and residual disease in lung cancer
Franziska Haderk, Celia Fernández-Méndez, Lauren Čech et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 18 citations · Full text
1–5 of 6